After proper training on subcutaneous injection technique, the prefilled syringe may be administered by the patient or caregiver.

Seismic Therapeutic has dosed the first healthy participant cohort in the randomised Phase I trial of bifunctional antibody S ...

Senti Biosciences, Inc.’s SNTI share price has dipped by 7.34%, which has investors questioning if this is right time to buy.

J&J exhibited additional findings, displaying that nipocalimab met its key secondary endpoint, a change in QMG score.